Hong Kong's IVD Medical Acquires $19M Ethereum for Treasury Strategy, Shares Surge 390% Since July 2025

By Naetitia

IVD Medical's $19M Ethereum Acquisition Through HashKey Partnership Marks Healthcare Sector's First Major Crypto Treasury Move

In a first for Hong Kong’s healthcare sector, IVD Medical Holding Ltd. (1931.HK) has acquired $19 million (HK$149 million) worth of ETH for its corporate treasury.

The move marks the first large-scale Ethereum reserve strategy by a Hong Kong-listed healthcare company.

Following the announcement, IVD’s share price surged from HK$7.8 to HK$9.8, representing a 25.64% increase, with an ongoing upward trend.

Notably, the stock has already gained 104.17% in August alone (from HK$4.8 to HK$9.8), and soared 390% over the past two months from just HK$2.0 in early July.

The acquisition is part of IVD’s global enhanced ETH vault strategy, designed to leverage Ethereum reserves while tokenizing innovative drug intellectual property to improve R&D efficiency and capital allocation.

Strategic Partnership with HashKey Group

The ETH purchase stems from a global strategic cooperation framework agreement with HashKey Group, a digital asset financial services provider licensed and regulated across Hong Kong, Singapore, Japan, and Bermuda.

Under the partnership:

• HashKey Exchange and HashKey OTC will execute large-scale ETH trades at favorable prices via over-the-counter channels, reducing transaction costs.

• HashKey Global will provide liquidity support for IVD’s ETH vault strategy, along with market insights and data analysis to guide investment decisions.

• Both parties will explore integrating crypto reserves with real economy assets, with HashKey offering technical and compliance support for converting drug IP into on-chain assets to enable global circulation and value realization.

A signing ceremony and ETH vault strategy upgrade conference will take place on August 11, 2025, at Three Exchange Square, Central, Hong Kong, featuring regulatory officials, industry leaders, and institutional investors, with a live broadcast via Roadshowchina and Futubull.

ETH Deployment in Healthcare Asset Tokenization

IVD will deploy the acquired ETH on its ivd.xyz platform, which tokenizes pharmaceutical IP and other healthcare assets using Ethereum smart contracts. The ETH will be used for:

• On-chain ownership confirmation and automated revenue distribution for tokenized assets.

• Acting as the settlement layer for the planned IVDD stablecoin, enabling cross-border transactions under Hong Kong and U.S. compliance frameworks.

• Automatically receiving revenue from real-world asset transactions, converted into ETH for treasury reserves.

• Staking, re-staking, and on-chain derivatives to enhance returns, liquidity, and downside protection.

Chief Strategy Officer Gary Deng said Ethereum was chosen because it is “the world’s most mature smart contract platform” with “extremely high liquidity” and increasing institutional adoption, citing the U.S. SEC’s approval of a spot ETH ETF.